Roche Holding"s (RHHBY) Virtual Late Stage Pipeline Event 2018 - Slideshow
Roche Holding"s (RHHBY) Virtual Late Stage Pipeline Event 2018 - Slideshow.....»»
Square moves investor day online while Fiserv moves its event to the fall due to coronavirus
Square Inc. announced late Tuesday that it would be hosting its investor day as a virtual event "to accommodate ongoing travel and workplace restrictions." The payments company will webcast its presentation on March 24 beginning at 8:30 a.m. PT......»»
Good Eggs cooks up next stage of expansion with new Oakland warehouse
The grocery delivery service signed the lease with Prologis for the new ground-up development back in late 2018......»»
The Ratings Game: Drug maker ChemoCentryx shares rocket on blockbuster potential in rare autoimmune disease
A set of conclusive findings from a late-stage clinical trial testing ChemoCentryx Inc.’s experimental vasculitis treatment surprised company executives and investors, who now say they are bullish on the sales and pipeline potential of avacopan......»»
Osmotica shares discounting late-stage pipeline, says Jefferies
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Roche Holding AG (RHHBY) CEO Severin Schwan on Q2 2019 Results - Earnings Call Transcript
Roche Holding AG (RHHBY) CEO Severin Schwan on Q2 2019 Results - Earnings Call Transcript.....»»
The Daily Biotech Pulse: Roche"s Flu Drug Aces Late-Stage Trial, Acura Outlicenses Pain Medication, Neuronetics Gets New Finance Chief
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 2) read more.....»»
Financial Markets To Federal Reserve: Time To Start Cutting Rates
Authored by John Rubino via DollarCollapse.com, In late 2018 the US stock market tanked, in effect holding a gun to its own head and threatening to pull the trigger unless the Fed stopped raising interest rates. The Fed, painfully aware.....»»
Raymond James Downgrades Ocular Therapeutix, Remains Bullish On Pipeline
Ocular Therapeutix Inc (NASDAQ: OCUL)'s failure to ace a late-stage study of its glaucoma treatment candidate has tempered Raymon.....»»
Myovant Shares Slide Despite Positive Late-Stage Data For Menstrual Bleeding Drug
Myovant Sciences Ltd (NYSE: MYOV) shares were trading sharply lower Tuesday despite seemingly positive news on the company's pipeline candidate for menstrual bleeding in women with uterine fibroids. read more.....»»
TG Therapeutics: Varied Pipeline With 2 Lead Candidates In Late Stage, Low Cash Position
TG Therapeutics: Varied Pipeline With 2 Lead Candidates In Late Stage, Low Cash Position.....»»
Roche Holding AG (RHHBY) CEO Severin Schwan on Q1 2019 Results - Earnings Call Transcript
Roche Holding AG (RHHBY) CEO Severin Schwan on Q1 2019 Results - Earnings Call Transcript.....»»
Aclaris Therapeutics (ACRS) Presents At William Blair Late-Stage Therapeutics Conference - Slideshow
Aclaris Therapeutics (ACRS) Presents At William Blair Late-Stage Therapeutics Conference - Slideshow.....»»
Eyenovia Reports Fourth Quarter and Full Year 2018 Financial Results
NEW YORK, March 27, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ:EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-pri.....»»
Y-mAbs Announces 2018 Financial Results and Corporate Development Highlights
NEW YORK, March 22, 2019 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the "Company" or "Y-mAbs") (NASDAQ:YMAB) a late-stage clinical bioph.....»»
Eisai Launches Confirmatory Late-Stage Trial Of Second Alzheimer"s Asset After Setback
Undeterred by the failure of one of its Alzheimer's pipeline assets, Eisai Co., Ltd (OTC: ESALY) is stepping up efforts to further advance its clinical pipeline. read more.....»»
Inovio Pharmaceuticals Reports 2018 Fourth Quarter and Year-End Financial Results
PLYMOUTH MEETING, Pa., March 12, 2019 /PRNewswire/ --Â Inovio Pharmaceuticals, Inc. (NASDAQ:INO), a late-stage biotechnology company focused on the development and commercialization of DNA immunotherapies targeted again.....»»
Minerva Neurosciences Reports Fiscal 2018 Fourth Quarter and Year End Financial Results and Business Updates
Recruitment active in five late-stage trials with three compounds direct.....»»
Here"s Why bluebird bio Gained 16.3% in February
The biopharma announced fourth-quarter 2018 operating results and reminded investors of its deep late-state pipeline......»»
PLx Pharma Inc. Reports Fourth Quarter 2018 Results
– Company Completes Successful $15 Million Financing – HOUSTON, March 08, 2019 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ:PLXP) ("PLx" or the "Company"), a late-stage specialty pharmaceutical company initially focused on developing its cli.....»»
Roche (RHHBY) Presents Encouraging Data on MS Drug Ocrevus
Roche (RHHBY) announces encouraging data on multiple sclerosis (MS) drug Ocrevus which reinforced the efficacy of drug in the long run. Roche Holding AG RHHBY announced enco.....»»